COVID-19 vaccine hesitancy in pregnacy
Authors: Rania Mansour, Mohammad S. Razai, Fatima Husain, Azeem Majeed, Pippa Oakeshott
Description: The health risks for pregnant women who contract COVID-19 disease are concerning. Unvaccinated pregnant women are more likely to require hospitalisation and treatment for COVID-19 compared to those vaccinated. Moreover, multiple studies report higher rates of intensive care admissions, greater requirement for invasive ventilation, and higher risk of death compared to non-pregnant women who have COVID-19. Approved COVID-19 vaccines are safe, effective, necessary, and important in pregnancy. Despite the protective effects of COVID-19 vaccination, uptake is very low among pregnant women compared to non-pregnant women in the UK and globally. Causes for vaccine hesitancy include lack of long-term safety data for COVID-19 vaccines, mixed messaging from healthcare providers, and mistrust of healthcare providers and the pharmaceutical industry. Strategies to improve vaccine roll-out include transparent, empathetic dialogue with pregnant women, recommendation by trusted sources of information such as a GP or midwife, offering vaccination during routine antenatal clinics, and generally making vaccination more convenient.
Description writer:
Rania Mansour, Graduate Medical Student, Population Health Research Institute, St George’s, University of London, UK
Mohammad S. Razai, In-Practice Fellow, Population Health Research Institute, St George’s, University of London, UK
Fatima Husain, Consultant in Obstetrics & Gynaecology, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Berkshire, UK
Azeem Majeed, Professor of Primary Care & Public Health, Department of Primary Care and Public Health, Imperial College London, UK
Pippa Oakeshott, Professor of General Practice, Population Health Research Institute, St George’s, University of London, UK